📰 Aruvant Sciences News
Aruvant Sciences News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Aruvant Sciences. Real-time updates on events, politics, business and more.
February 7, 2024
NEW YORK and BERLIN, Feb. 06, 2024 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ:ATAI) ("atai" or "Company") today announced that Anne Johnson, the Company's interim Chief Financial Officer since October 2023 and
February 6, 2024
NEW YORK and BERLIN, Feb. 06, 2024 -- atai Life Sciences today announced that Anne Johnson, the Company’s interim Chief Financial Officer since October 2023 and Chief Accounting Officer since...
January 16, 2024
/PRNewswire/ -- DelveInsights AAV Vectors in Gene Therapy Market Insights report includes a comprehensive understanding of current treatment practices,...
June 9, 2023
/PRNewswire/ -- The "Gene Amplification Technologies Market Report 2023-2033" report has been added to ResearchAndMarkets.coms offering. The Gene...
May 30, 2023
Major players in the hypophosphatasia treatment market are Kirin Holdings Company Limited, Vericel Corporation, Mereo Biopharma Group Plc., Novartis AG,...
May 22, 2023
/PRNewswire/ -- DelveInsights Sickle Cell Disease Market Insights report includes a comprehensive understanding of current treatment practices, sickle cell...
May 22, 2023
According to DelveInsight's estimates, the sickle cell disease market size in the 7MM is expected to show positive growth, during the forecast period (2023-2032), mainly attributed to the increasing
April 5, 2023
/PRNewswire/ -- The "Global Genetic Disorders Partnering 2016-2023: Deal trends, players and financials" report has been added to ResearchAndMarkets.coms...
November 28, 2022
Experienced financial executive in building corporate value and capital fundraising NEW YORK, Nov. 28, 2022 /PRNewswire/ -- Promontory Therapeu...
November 28, 2022
/PRNewswire/ -- Promontory Therapeutics Inc., a clinical stage pharmaceutical company advancing small molecule immunotherapies in oncology, today announced the...